Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea.
Kidney Res Clin Pract. 2013 Dec;32(4):177-82. doi: 10.1016/j.krcp.2013.10.002. Epub 2013 Nov 25.
Cardiovascular disease is the main cause of mortality in dialysis patients. Carotid intima-media thickness (CIMT) is used as a surrogate marker of early atherosclerosis. Atherosclerosis can cause vascular access failure. The purpose of this study was to define the clinical features of atherosclerosis in hemodialysis patients based on CIMT and to define the relationship between CIMT and access failure.
In this cross-sectional study, the CIMT of 60 patients on hemodialysis was examined using B-mode Doppler ultrasonography between May 2012 and November 2012. Carotid atherosclerosis was defined as a CIMT≥0.9 mm or the incidence of atherosclerotic plaques.
The patients' mean age was 54.5±10.6 years, and 60% of the patients were male. The CIMT was 0.81±0.47 mm (range, 0.35-2.50 mm). The group with atherosclerosis was characterized by older age compared with those without atherosclerosis. Patients with atherosclerosis showed much shorter durations of access patency than their counterparts in the nonatherosclerosis group (hazard ratio, 2.822; 95% confidence interval, 1.113-7.156; P=0.029). Moreover, being overweight was associated with a 2.47-fold (95% confidence interval, 1.101-5.548) increased primary access failure.
This study shows that atherosclerosis is associated with older age. Patients who are overweight and have atherosclerosis may have shortened access patency.
心血管疾病是透析患者死亡的主要原因。颈动脉内膜中层厚度(CIMT)可用作早期动脉粥样硬化的替代标志物。动脉粥样硬化可导致血管通路失败。本研究旨在根据 CIMT 定义血液透析患者的动脉粥样硬化临床特征,并定义 CIMT 与通路失败之间的关系。
在这项横断面研究中,于 2012 年 5 月至 2012 年 11 月期间使用 B 型多谱勒超声检查了 60 名血液透析患者的 CIMT。颈动脉粥样硬化定义为 CIMT≥0.9mm 或动脉粥样硬化斑块的发生率。
患者的平均年龄为 54.5±10.6 岁,60%的患者为男性。CIMT 为 0.81±0.47mm(范围,0.35-2.50mm)。与无动脉粥样硬化组相比,动脉粥样硬化组的患者年龄较大。动脉粥样硬化组患者的通路通畅时间明显短于非动脉粥样硬化组(风险比,2.822;95%置信区间,1.113-7.156;P=0.029)。此外,超重与原发性通路失败的风险增加 2.47 倍(95%置信区间,1.101-5.548)相关。
本研究表明动脉粥样硬化与年龄较大有关。超重且患有动脉粥样硬化的患者可能会缩短通路通畅时间。